Results 161 to 170 of about 24,414 (214)

Analysis of Keratoconus-Related Phenotypes in Two Pcsk1 Mouse Models. [PDF]

Transl Vis Sci Technol
Beatty C, Cai J, Yu H, Sun J, Heo Y, Baratz KH, Bernhisel AA, Patel SV, Estes AJ, Kuo AN, Liu Y.   +10 more
europepmc   +1 more source

Antioxidant Activity and Potential Cholesterol Modulating Effect of Punica granatum L. Peel Hydroethanolic Extract. [PDF]

Chem Biodivers
Chaaba R, Nakbi A, Rossi I, Jrah H, Amri Z, Ferri N, Hammami S, Dall'Acqua S, Hammami M, Mehri S.   +9 more
europepmc   +1 more source

Evolocumab-induced allergic reaction in a post-partial gastrectomy patient: A case report. [PDF]

Medicine (Baltimore)
Hong X, Jiang X, Xu X, Xiong F, Huang X.
europepmc   +1 more source

Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy. [PDF]

Mol Biomed
Fan G, Zha J, Chen S, Cang P, Zhang Q, Yang J, Liu M.   +6 more
europepmc   +1 more source

Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipid Profile and Cardiovascular Events in High-Risk Diabetic Patients. [PDF]

Cureus
Patra V, Yella VR, Konda VGR, Sayana SB, Siripuram C, Konka S, Kandimalla R.   +6 more
europepmc   +1 more source

PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]

Sci Rep
Akhtar W, Khan T, Neves E, Browne C, Tawil M, Lyster H, Dar O.   +6 more
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy. [PDF]

JACC Asia
Zeng RX, Li S, Li JJ.
europepmc   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

Optimizing low-density lipoprotein cholesterol (LDL-C) management - a US physician survey of barriers and burdens. [PDF]

Am J Prev Cardiol
Leiter LA, Karmarkar T, Bash LD, Exter J, Schmier JK, Jayade SP, Roney KC, Simpson RJ, Baum SJ.   +8 more
europepmc   +1 more source